Skip to main content
Top

Current Cardiology Reports

Issue 6/2014

Content (11 Articles)

Genetics of Valvular Heart Disease

  • Cardiovascular Genomics (R McPherson, Section Editor)

Stephanie LaHaye, Joy Lincoln, Vidu Garg

Towards a Molecular Systems Model of Coronary Artery Disease

  • Open Access
  • Cardiovascular Genomics (R McPherson, Section Editor)

Gad Abraham, Oneil G. Bhalala, Paul I. W. de Bakker, Samuli Ripatti, Michael Inouye

Ischemic Heart Disease and the Mediterranean Diet

  • Ischemic Heart Disease (D Mukherjee, Section Editor)

Thomas F. Whayne Jr.

Aortic Valve Repair: Indications and Outcomes

  • Valvular Heart Disease (VT Nkomo, Section Editor)

Munir Boodhwani, Gebrine El Khoury

Approval of High-Risk Medical Devices in the US: Implications for Clinical Cardiology

  • Public Health Policy (NK Choudhry, Section Editor)

Benjamin N. Rome, Daniel B. Kramer, Aaron S. Kesselheim

Universal MI Definition Update for Cardiovascular Disease

  • New Therapies for Cardiovascular Disease (KW Mahaffey, Section Editor)

Harvey White, Kristian Thygesen, Joseph S. Alpert, Allan Jaffe

Cangrelor: Review of the Drug and the CHAMPION Programme (Including PHOENIX)

  • New Therapies for Cardiovascular Disease (KW Mahaffey, Section Editor)

Marcello Marino, Diego Rizzotti, Sergio Leonardi

Overview of the US FDA Medical Device Approval Process

  • New Therapies for Cardiovascular Disease (KW Mahaffey, Section Editor)

Ashwani Sastry

Catheter-Based Therapies for Deep Vein Thrombosis

  • Peripheral Vascular Disease (MH Shishehbor, Section Editor)

Mahmood K. Razavi, Emmad Karmouta

ICD Programming to Reduce Shocks and Improve Outcomes

  • Invasive Electrophysiology and Pacing (EK Heist, Section Editor)

Valentina Kutyifa, Wojciech Zareba, Arthur J. Moss

Pathophysiology, Prevention, and Treatment of Commotio Cordis

  • Invasive Electrophysiology and Pacing (EK Heist, Section Editor)

Mark S. Link

Next-generation MRI contrast agents: preparing the field (Link opens in a new window)

New MRI contrast agents are reshaping diagnostic imaging, promising lower gadolinium exposure amid evolving practice guidelines. How can you optimise contrast selection, dosing, and patient care in this rapidly advancing field?

This content is intended for healthcare professionals outside of the UK.

Independent Medical Education Grant:
  • Bayer HealthCare Pharmaceuticals Inc.
Learn more Link opens in a new window
Image Credits
Abstract graphic of layered, concentric circular shapes in bright green, pink, blue, and purple on a dark blue background. The rings and segments form a complex radial pattern without text/© Springer Health+ IME